Immunomedics, Inc. (NASDAQ:IMMU) soared 3.27% during previous trade, a total of 3.65M shares exchanged hands compared with its average trading volume of 5.65M shares whereas its relative volume is 0.97. The stock has a market capitalization of $711.06M along with 106.08M outstanding shares. Stock’s intraday price range hit the peak level of $6.85 and touched the lowest level of $6.43.
Most recently Immunomedics, Inc. (NASDAQ:IMMU)’s price target was revised on 2/10/17 and according to 1 analyst stock’s price will reach at $7.50 during 52 weeks with standard deviation of 0.00. Stock’s minimum price target estimates has been figured out at $7.50 while the maximum price target forecast is established at $7.50, if we look at the price target with an optimistic approach it has upside potential of 13% from its latest closing price of $6.63.
Historically, if we look at price target revisions, two weeks ago Immunomedics, Inc. (NASDAQ:IMMU)’s price target was revised on 02/10/17 by the analysts, however the bullish price estimates of the stock set at $7.50 while the bearish estimates kept at $7.50 over the next one year. Stock’s 52-week target was retained at $7.50, the estimates indicates a standard deviation of 0.00.
While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 2.00. ABR value is precisely based on brokerage recommendations, where out of 2 brokerage recommendations 1 rate Immunomedics, Inc. (NASDAQ:IMMU) stock a Strong Buy, 0 rate the stocks of the company a Buy, 1 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 6/21/16 the stock of Immunomedics, Inc. (NASDAQ:IMMU) downgraded by Wells Fargo from Outperform to Market Perform. However previously on 5/6/16 it was upgraded by Jefferies from Hold to Buy. A research note issued on 7/29/15 the stock was downgraded by Jefferies from Buy to Hold.
Immunomedics, Inc. (NASDAQ:IMMU) performance over the past one year soared 167.34% whereas its year to date (YTD) performance indicated a bullish trend of 80.65%. During the last six months the stock climbed 100.91%. Quarterly performance of the company shows optimistic momentum of 77.27% while its last one month trend is positive with 33.67%. Stock’s weekly performance expressed up trend of 7.11%.
The company’s price sits 33.45% above from its 50-day moving average of $5.35 and 94.67% far from the stock’s 200-day moving average which is $3.76. Immunomedics, Inc. (NASDAQ:IMMU)’s shares are currently trading -0.30% away from the 52-week high price of $6.65 and +240% far from the 52-week low price of $1.95.
According to consensus agreement of 2 analysts Immunomedics, Inc. (NASDAQ:IMMU) will report earnings per share of $-0.13 in their quarterly report and it is expected to announce the company’s results on 5/3/17. For the current quarter the company has high EPS estimates of $-0.11 in contradiction of low EPS estimates of $-0.15. However a year ago for the same quarter the company has reported $-0.17 EPS. Current year EPS projections for Immunomedics, Inc. (NASDAQ:IMMU) set at $-0.61 according to the sentiments of 2 analysts, while its lowest earnings estimates are $-0.63 and highest earnings estimates are $-0.58.
According to 2 analysts, Immunomedics, Inc. (NASDAQ:IMMU)’s revenue estimates for the current quarter are $3.2M meanwhile the company has high revenue estimates of $5.5M in contradiction of low revenue estimates of $900K. For the current year the company’s revenue estimates are $15.05M compared to low analyst estimates of $9.1M and high estimates of $21M according to the projection of 2 analysts.